Clinical Trial Detail

NCT ID NCT01847001
Title Study of Propranolol in Newly Diagnosed Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Columbia University
Indications

breast cancer

Therapies

Propranolol

Paclitaxel + Pertuzumab + Trastuzumab

Age Groups: adult

No variant requirements are available.